HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Myoinositol--alternative treatment of insulin resistance in adolescents].

Abstract
Myo-inostitol is a part of inositolphosphoglycan (IPG) mediators, which are known as putative mediators of insulin. One of the theories for insulin resistance is any deficiency in Myo-inositol. Presumably a substitution therapy with exogenous Myo-inositol could be effective for treatment of insulin resistance and PCOS. This is well established in women in reproductive age, but there is insufficient data for adolescence.
AuthorsS Kedikova, M Sirakov, M Boyadzhieva
JournalAkusherstvo i ginekologiia (Akush Ginekol (Sofiia)) Vol. 50 Issue 7 Pg. 16-9 ( 2011) ISSN: 0324-0959 [Print] Bulgaria
PMID22452173 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Inositol Phosphates
  • Insulin
  • Polysaccharides
  • inositol phosphate glycan
  • Inositol
Topics
  • Adolescent
  • Female
  • Humans
  • Inositol (therapeutic use)
  • Inositol Phosphates (metabolism)
  • Insulin (metabolism)
  • Insulin Resistance
  • Polycystic Ovary Syndrome (drug therapy)
  • Polysaccharides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: